These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32104340)

  • 21. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
    Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
    Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency.
    Tang J; Chen JY; Liu J; Luo M; Wang YJ; Wei XW; Gao X; Wang BL; Liu YB; Yi T; Tong AP; Song XR; Xie YM; Zhao Y; Xiang M; Huang Y; Zheng Y
    Int J Pharm; 2012 Jul; 431(1-2):210-21. PubMed ID: 22561795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and Evaluation of Irinotecan Poly(Lactic-co-Glycolic Acid) Nanoparticles for Enhanced Anti-tumor Therapy.
    Yang X; Yang Y; Jia Q; Hao Y; Liu J; Huang G
    AAPS PharmSciTech; 2019 Feb; 20(3):133. PubMed ID: 30820689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance.
    Zhu H; Chen H; Zeng X; Wang Z; Zhang X; Wu Y; Gao Y; Zhang J; Liu K; Liu R; Cai L; Mei L; Feng SS
    Biomaterials; 2014 Feb; 35(7):2391-400. PubMed ID: 24360574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly (Lactic-Co-Glycolic) Acid-Poly (Vinyl Pyrrolidone) Hybrid Nanoparticles to Improve the Efficiency of Oral Delivery of β-Carotene.
    Liu WY; Hsieh YS; Wu YT
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal efficacy of Itraconazole loaded PLGA-nanoparticles stabilized by vitamin-E TPGS: In vitro and ex vivo studies.
    Alhowyan AA; Altamimi MA; Kalam MA; Khan AA; Badran M; Binkhathlan Z; Alkholief M; Alshamsan A
    J Microbiol Methods; 2019 Jun; 161():87-95. PubMed ID: 30738109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.
    Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U
    Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of superparamagnetic iron oxide/doxorubicin co-loaded poly (lactic-co-glycolic acid) nanospheres prepared by different emulsion solvent evaporation methods.
    Mosafer J; Teymouri M
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1146-1155. PubMed ID: 28789586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations.
    Tariq M; Alam MA; Singh AT; Iqbal Z; Panda AK; Talegaonkar S
    Colloids Surf B Biointerfaces; 2015 Apr; 128():448-456. PubMed ID: 25769281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles.
    Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K
    Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral.
    Italia JL; Bhatt DK; Bhardwaj V; Tikoo K; Kumar MN
    J Control Release; 2007 Jun; 119(2):197-206. PubMed ID: 17399839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The binary complex of poly(PEGMA-co-MAA) hydrogel and PLGA nanoparticles as a novel oral drug delivery system for ibuprofen delivery.
    Shang Q; Huang S; Zhang A; Feng J; Yang S
    J Biomater Sci Polym Ed; 2017 Nov; 28(16):1874-1887. PubMed ID: 28693380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles.
    Varshosaz J; Taymouri S; Hamishehkar H; Vatankhah R; Yaghubi S
    Res Pharm Sci; 2017 Jun; 12(3):222-232. PubMed ID: 28626480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved Stability and Enhanced Oral Bioavailability of Atorvastatin Loaded Stearic Acid Modified Gelatin Nanoparticles.
    Shilpi D; Kushwah V; Agrawal AK; Jain S
    Pharm Res; 2017 Jul; 34(7):1505-1516. PubMed ID: 28466393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety Profiles of Oral Atorvastatin-Loaded Nanoparticles: Effect of Size Modulation on Biodistribution.
    Ahmed IS; El Hosary R; Hassan MA; Haider M; Abd-Rabo MM
    Mol Pharm; 2018 Jan; 15(1):247-255. PubMed ID: 29232954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preparation and in vitro evaluation of pDNA-CaPi-PLGA nanoparticles with a core-shell structure].
    Tang J; Liu J; Hu TT; Yang CL; Guo G; He G; Huang Y; Zheng Y
    Yao Xue Xue Bao; 2013 Feb; 48(2):298-304. PubMed ID: 23672030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly((D,L)lactic-glycolic)acid-star glucose nanoparticles for glucose transporter and hypoglycemia-mediated tumor targeting.
    Park JH; Cho HJ; Kim DD
    Int J Nanomedicine; 2017; 12():7453-7467. PubMed ID: 29066894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ramizol
    Wright L; Rao S; Thomas N; Boulos RA; Prestidge CA
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1451-1457. PubMed ID: 29619851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.